MET and hepatocellular carcinoma: A recent study using HepG2 cells, as an in vitro HCC model, demonstrated that c‐Met‐specific CAR‐NK cells have specific and more potent cytotoxicity against c‐Met‐positive HepG2 cells than the lung cancer cell line, H1299, with lower c‐Met expression.74